Posted on 12/28/2011 7:30:15 PM PST by Nachum
Two independent groups working with advanced-stage cases say the drug extended the period before the disease worsened by more than 3.5 months.
Avastin can stabilize tumors in women suffering from advanced-stage ovarian cancer, extending the period before the disease worsens by more than 3.5 months, according to the results of two large, international clinical trials conducted by separate research teams.
The findings, published in Thursday's edition of the New England Journal of Medicine, come less than a week after the European Commission approved Avastin for treating women newly diagnosed with advanced ovarian cancer. The drug, known generically as bevacizumab, has not yet been approved by the Food and Drug Administration to treat ovarian cancer in the U.S.
Though Avastin has not been shown to prolong the lives of women with ovarian cancer and does come with significant side effects, it offers some hope for treating what remains the deadliest of gynecologic cancers, researchers said.
(Excerpt) Read more at latimes.com ...
The list, Ping
Let me know if you would like to be on or off the ping list
It’s also been used “off label” to treat macular degeneration effectively—I know because I use it, but the FDA won’t approve it for that either.
With ObamaCare's death panels, we haven't got a prayer.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.